Immune deviation

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immune deviation.php on line 2
Immune deviation

LE WE PMID CA

Immune deviation

3337

Immundeviation

Anisakiasis

Bacteria (Commensal)

Belatacept ttCD80 ttCD86

DINAC

Ecstasy

Imiquimod

Immune deviation

Immunosuppressive agents

Innate immunity

Kidney (Minimal change nephrotic syndrome)

Macrophages

Malaria

Murabutide

Regulatory T cell

Resiquimod

Segmented filamentous bacteria

Sepsis

T cell (Th17)

Transfusion (BASKET)

Ultraviolet radiation (Therapeutic use)

Vasoactive intestinal peptide

2003 1	Immunomodulation by antimicrobial drugs. [14567518] Neth J Med 61(7): 233-4 (2003)
1990 2	Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection. [2293502] Yale J Biol Med 63(5): 429-33 (1990)
1996 3	Blood transfusion-induced immunomodulation. [8712400] Anesth Analg 82(1): 187-204 (1996)
1990 4	The effect of anesthetic agents on the human immune response. [2178494] Anesthesiology 72(3): 542-52 (1990)
1971 5	Anesthesia and the immune response. [5544626] Anesthesiology 34(3): 271-82 (1971)
2004 6	Clinical review: immunomodulatory effects of dopamine in general inflammation. [15566620] Crit Care 8(6): 485-91 (2004)
2003 7	The antiatherogenic effect of DiNAC: experimental findings supporting immunomodulation as a new treatment for atherosclerosis related diseases. [12847563] Cardiovasc Drug Rev 21(2): 119-32 (2003)
2008 8	Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction. [18026131] Br J Pharmacol 153 Suppl 1(-): S27-34 (2008)
2007 9	The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept. [19707331] Biologics 1(3): 203-13 (2007)
2004 10	The significance of vasoactive intestinal peptide in immunomodulation. [15169929] Pharmacol Rev 56(2): 249-90 (2004)
2003 11	Mechanisms involved in ultraviolet light-induced immunosuppression. [14721768] Eur J Dermatol 13(6): 515-23 (2003)
2009 12	B-cell-directed therapy for inflammatory skin diseases. [19148218] J Invest Dermatol 129(2): 289-301 (2009)
1992 13	Use of immune modulators in nonspecific therapy of bacterial infections. [1590674] Antimicrob Agents Chemother 36(1): 1-5 (1992)
2003 14	Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide. [12493780] J Antimicrob Chemother 51(1): 5-8 (2003)
2001 15	Imiquimod and resiquimod as novel immunomodulators. [11733457] J Antimicrob Chemother 48(6): 751-5 (2001)
1966 16	Symposium on in vitro studies of the immune response. 3. Biochemical agents affecting the inductive phase of the secondary antibody respose initiated in vitro. [5327954] Bacteriol Rev 30(2): 408-17 (1966)
1966 17	Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses. [5327460] Bacteriol Rev 30(2): 442-59 (1966)
2000 18	Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? [11023961] Clin Microbiol Rev 13(4): 615-50 (2000)
2000 19	Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. [11023954] Clin Microbiol Rev 13(4): 523-33 (2000)
1996 20	Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. [8894351] Clin Microbiol Rev 9(4): 532-62 (1996)
1996 21	Immune deviation: a historical perspective. [8912008] Immunol Cell Biol 74(5): 449-56 (1996)
2002 22	Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors. [12522440] Cancer Gene Ther 9(12): 1013-21 (2002)
2002 23	The cellular basis of post-burn immunosuppression: macrophages and mediators. [12165794] Int J Mol Med 10(3): 239-43 (2002)
2010 24	Parasitic helminths: new weapons against immunological disorders. [20169100] J Biomed Biotechnol 2010(-): 743758 (2010)
2010 25	Similarity and diversity in macrophage activation by nematodes, trematodes, and cestodes. [20145705] J Biomed Biotechnol 2010(-): 262609 (2010)
2010 26	Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern? [20718737] Br J Pharmacol 161(1): 17-32 (2010)
2010 27	New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression. [20146712] Ann N Y Acad Sci 1183(-): 123-48 (2010)
2008 28	Anisakis simplex: from obscure infectious worm to inducer of immune hypersensitivity. [18400801] Clin Microbiol Rev 21(2): 360-79, table of contents (2008)
2011 29	Epigenetic regulation of immune cell functions during post-septic immunosuppression. [21048427] Epigenetics 6(3): 273-83 (2011)
2010 30	What can we learn from an unnatural immune response? [20430697] Trends Parasitol 26(7): 319-21 (2010)
2010 31	Segmented filamentous bacteria take the stage. [20147894] Mucosal Immunol 3(3): 209-12 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immune deviation.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immune deviation.php on line 92